BREAKING NEWS

Teva launches generic blood pressure treatments

By GLOBES

APRIL 2, 2012 11:43

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced Monday that it has commenced commercial launch of both Irbesartan and Irbesartan-Hydrochlorothiazide Tablets, its generic versions of Sanofi Aventis’s high blood pressure treatments, Avapro and Avalide Tablets.

Teva reports that the brand products had annual sales of approximately $464 million and $124 million, respectively in the US, according to IMS sales data.

As the first company to file Abbreviated New Drug Applications (ANDA) containing paragraph IV certifications for both of these products, Teva has been awarded a 180-day period of marketing exclusivity.

Biden, Netanyahu talk after start of Rafah evacuation

By JERUSALEM POST STAFF

05/06/2024 05:16 PM

Hamas hostage deal talks on hold, official claims - report

By JERUSALEM POST STAFF

05/06/2024 05:07 PM

Columbia cancels commencement due to pro-Palestine protests

By REUTERS

05/06/2024 04:17 PM

Visits to Israel still down amid war - CBS

By EVE YOUNG

05/06/2024 03:28 PM